Twinbeech Capital LP Apellis Pharmaceuticals, Inc. Put Options Transaction History
Twinbeech Capital LP
- $4.02 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
306Shares Held
128MCall Options Held
2.96MPut Options Held
623K-
Avoro Capital Advisors LLC New York, NY12.2MShares$242 Million3.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.99MShares$198 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.75MShares$193 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA9.29MShares$184 Million0.04% of portfolio
-
Deep Track Capital, LP Greenwich, CT7MShares$139 Million4.3% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.18B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...